Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vitiligo]

M D Njoo1, W Westerhof

  • 1Academisch Medisch Centrum, Nederlands Instituut voor Pigmentstoornissen, Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|April 19, 1997
PubMed
Summary
This summary is machine-generated.

Vitiligo is a skin disorder causing white patches due to melanocyte loss, affecting 1-2% of the population. Treatments include repigmentation and, in severe cases, total depigmentation therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry Study.

Drugs & aging·2022
Same author

Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Twenty-year follow-up using a postal survey of childhood vitiligo treated with narrowband ultraviolet B phototherapy.

The British journal of dermatology·2017
Same author

Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.

The British journal of dermatology·2016
Same author

Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort.

The British journal of dermatology·2016
Same author

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry.

The British journal of dermatology·2016
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Area of Science:

  • Dermatology and Autoimmunology: Focuses on skin disorders and the immune system's role.

Context:

  • Vitiligo is a prevalent skin condition characterized by depigmented patches resulting from melanocyte loss.
  • Affects 1-2% of the population, typically emerging between ages 10-30, with equal prevalence in males and females.
  • Often presents with a progressive course, interspersed with periods of stability, and is frequently associated with other autoimmune diseases.

Purpose:

  • To provide a comprehensive overview of vitiligo, including its clinical presentation, epidemiology, and hypothesized etiologies.
  • To outline current therapeutic strategies for vitiligo management, encompassing repigmentation and depigmentation options.

Summary:

  • Vitiligo is defined by the symmetrical, demarcated white patches on the skin due to melanocyte absence.
  • Etiology remains unknown, with hypotheses including genetic predisposition, autoimmunity, neurological factors, and cellular self-destruction.

Related Experiment Videos

  • Treatment modalities include photochemotherapy, corticosteroids, and melanocyte transplantation for repigmentation; total depigmentation is an option for extensive cases.

    • Impact:

    • Highlights the need for further research into vitiligo's unknown cause.
    • Informs clinical practice regarding the range of therapeutic interventions available for vitiligo patients.
    • Provides a foundation for understanding the management of this chronic autoimmune skin condition.